Get started
Author

Temitope Isaac Adelusi

Observed names: Adelusi Temitope I, Adelusi, T. I., Adelusi, Temitope I., Adelusi, Temitope Isaac, Isaac Adelusi Temitope, T Adelusi, Temitope Isaac Adelusi, Temitope Adelusi, Temitope I Adelusi, Temitope I. Adelusi, Temitope Isaac Adelus
ORCID: 0009-0001-7835-8040
Observed ORCIDs: 0009-0001-7835-8040, 0000-0002-6342-8624
OpenAlex ID: A5059326526
Molecular modeling in drug discovery
2022 · Temitope Isaac Adelusi, Abdul-Quddus Kehinde Oyedele, et al. · Informatics in Medicine Unlocked · 387
PDF
Keap1/Nrf2/ARE signaling unfolds therapeutic targets for redox imbalanced-mediated diseases and diabetic nephropathy
2020 · Temitope Isaac Adelusi, Lei Du, et al. · Biomedicine & Pharmacotherapy · 131
PDF
Current etiological comprehension and therapeutic targets of acetaminophen-induced hepatotoxicity
2020 · Apu Chowdhury, Jahan Nabila, et al. · Pharmacological Research · 102
In silico investigation of saponins and tannins as potential inhibitors of SARS-CoV-2 main protease (Mpro)
2021 · Victoria Adeola Falade, Temitope Isaac Adelusi, et al. · In Silico Pharmacology · 61
PDF
Direct Keap1-kelch inhibitors as potential drug candidates for oxidative stress-orchestrated diseases: A review on In silico perspective
2021 · Ibrahim Damilare Boyenle, Ukachi Chiamaka Divine, et al. · Pharmacological Research · 59
Mangiferin ameliorates acetaminophen-induced hepatotoxicity through APAP-Cys and JNK modulation
2019 · Apu Chowdhury, Jihong Lu, et al. · Biomedicine & Pharmacotherapy · 56
PDF
Molecular dynamics, quantum mechanics and docking studies of some Keap1 inhibitors – An insight into the atomistic mechanisms of their antioxidant potential
2021 · Temitope Isaac Adelusi, Misbaudeen Abdul-Hammed, et al. · Heliyon · 54
PDF
Docking covalent targets for drug discovery: stimulating the computer-aided drug design community of possible pitfalls and erroneous practices
2022 · Abdul-Quddus Kehinde Oyedele, Abdeen Tunde Ogunlana, et al. · Molecular Diversity · 52
PDF
Targeting the mitochondrial permeability transition pore for drug discovery: Challenges and opportunities
2022 · Ibrahim Damilare Boyenle, Abdulquddus Kehinde Oyedele, et al. · Mitochondrion · 48
Consensus scoring-based virtual screening and molecular dynamics simulation of some TNF-alpha inhibitors
2021 · Ibrahim Damilare Boyenle, Temitope Isaac Adelusi, et al. · Informatics in Medicine Unlocked · 37
PDF
Bioinformatics, Computational Informatics, and Modeling Approaches to the Design of mRNA COVID-19 Vaccine Candidates
2022 · Olugbenga Oluwagbemi, Elijah Oladipo, et al. · Computation · 34
PDF
AMPK allostery: A therapeutic target for the management/treatment of diabetic nephropathy
2020 · Kehinde Sulaimon Ayinde, Olamide Tosin Olaoba, et al. · Life Sciences · 34
Neurotrophic, anti-neuroinflammatory, and redox balance mechanisms of chalcones
2020 · Temitope Isaac Adelusi, Gbemisola Rebecca Akinbolaji, et al. · European Journal of Pharmacology · 30
Dietary polyphenols mitigate SARS-CoV-2 main protease (Mpro)–Molecular dynamics, molecular mechanics, and density functional theory investigations
2021 · Temitope Isaac Adelusi, Abdul-Quddus Kehinde Oyedele, et al. · Journal of Molecular Structure · 29
Signaling pathways and proteins targeted by antidiabetic chalcones
2020 · Temitope Isaac Adelusi, Lei Du, et al. · Life Sciences · 28
Targeted Therapy for Highly Desmoplastic and Immunosuppressive Tumor Microenvironment of Pancreatic Ductal Adenocarcinoma
2024 · Olamide T. Olaoba, Ming Yang, et al. · Cancers · 27
PDF
Driver Mutations in Pancreatic Cancer and Opportunities for Targeted Therapy
2024 · Olamide T. Olaoba, Temitope I. Adelusi, et al. · Cancers · 26
Molecular Mechanics with Generalized Born Surface Area (MMGBSA) Calculations and Docking Studies Unravel some Antimalarial Compounds Using Heme O Synthase as Therapeutic Target
2023 · Temitope Isaac Adelusi, Olawale Quadri Bolaji, et al. · ChemistrySelect · 24
Quantitative profiling of neurotransmitter abnormalities in brain, cerebrospinal fluid, and serum of experimental diabetic encephalopathy male rat
2017 · Xiaowen Han, Mengjun Min, et al. · Journal of Neuroscience Research · 24
Exploring the inhibitory potentials of Momordica charantia bioactive compounds against Keap1-Kelch protein using computational approaches
2021 · Temitope Isaac Adelusi, Misbaudeen Abdul-Hammed, et al. · In Silico Pharmacology · 23
Integrated virtual screening and molecular dynamics simulation revealed promising drug candidates of p53-MDM2 interaction
2022 · Abdul-Quddus Kehinde Oyedele, Temitope Isaac Adelusi, et al. · Journal of Molecular Modeling · 20
Computer-aided drug design of some KRAS G12C inhibitors: Targeting the covalent and allosteric binding site for cancer therapy
2022 · Abdeen Tunde Ogunlana, Abdul-Quddus Kehinde Oyedele, et al. · Informatics in Medicine Unlocked · 18
PDF
A variation in KCNQ1 gene is associated with repaglinide efficacy on insulin resistance in Chinese Type 2 Diabetes Mellitus Patients
2016 · Xueyan Zhou, Jing Zhu, et al. · Scientific Reports · 18
PDF
Functional foods’ bioactive components and their chemoprevention mechanism in cervical, breast, and liver cancers: A systematic review
2021 · John Oluwafemi Teibo, Kehinde Sulaimon Ayinde, et al. · Functional Foods in Health and Disease · 17
PDF
A secondary approach with conventional medicines and supplements to recuperate current COVID-19 status
2021 · Apu Chowdhury, Muhammad Sajid, et al. · Biomedicine & Pharmacotherapy · 17
PDF
Works count: 66
Citation count: 1,523
H-index: 20
I10-index: 30
Year
Topic
Type